# Evercurious VC

> Evercurious VC is a VC fund backing Health Care and Medical. See 8 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 8
- Last investment: Jun 2026
- Lead investor: 63%
- Last updated: Aug 2026

Evercurious VC is a VC fund focused on Health Care and Medical. Early stage deep-tech VC firm

## Contacts

5 contacts available for Evercurious VC. Shizune tracks 2 team members at Evercurious VC. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/evercurious-vc?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.2M–$7.7M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 25% |
| Medical | 1 | 13% |
| Chemical | 1 | 13% |
| Software | 1 | 13% |
| Training | 1 | 13% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 63% |
| Pre-Seed | 1 | 13% |
| Series A | 1 | 13% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 2 | 25% |
| Belgium | 1 | 13% |
| Germany | 1 | 13% |
| United States | 1 | 13% |
| The Netherlands | 1 | 13% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alex Vamvakas | Partner | 5 | https://shizune.co/investors/profile/alex-vamvakas |
| George Georgiadis | Partner | 1 | https://shizune.co/investors/profile/george-georgiadis-3bba |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Anodyne Nanotech | Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs. Its first practical and cost-effective platform, Hero Patch, delivers clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules for fast and sustained delivery.The company was founded in2019 by Jake Lombardo, Konstantinos Tzortzakis, and Hojatollah Rezaei Nejad. | $12.6M | Series A | Jun 24, 2026 |  |
| SolidWatts | SolidWatts enable the electrification of power-hungry industrial processes that require heat to fulfill a process. | $2.3M | Seed | Mar 25, 2026 |  |
| Co-reactive | Co-reactive is a ClimateTech startup that provides decarbonization of the construction industry at scale. Co-reactive works with suppliers of CO₂ and raw materials, manufacturers of cement and concrete, and certification bodies throughout the value chain to scale from pilot plants to large industrial units in the range of 100–300 kilotons. Feedback | $7.7M | Seed | Jan 27, 2026 |  |
| ORamaVR | ORamaVR (www.oramavr.com) is a deep technology, spatial computing startup, innovating the field of med-ed-tech Virtual Reality (VR) training simulation authoring platforms. Our technologies are based on state-of-the-art research by world-renowned scientists team members. This research is turned into a novel, symbiotic VR authoring and simulationplatform by our top engineers, medical professionals and business developers. ORamaVR was founded in 2016 and received initial €575K pre-seed financing from the VC PJ TECH CATALYST FUND in Greece. The company has moved its HQ to Geneva, Switzerland upon strategic partners' demand. ORamaVR is adopted by the USC Keck School of Medicine, Los Angeles, NYU Langone Medical centre in New York, the University of Geneva and the Inselspital Hospital system in Switzerland, FORTH and the University of Athens in Greece and recently Western Governors University, Fayetteville State University and the University of Michigan in USA. Medacta International, a leading Swiss medical implant manufacturer expressed high interest to collaborate intensively with ORamaVR. ORamaVR has been awarded in 2020 an Epic Games Mega-Grant, in 2019 the Augmented World Expo (AWE) Auggie award for "Best Societal Impact” and the prestigious FARE award, from the American Association of Hip and Knee Surgeons (AAHKS) in 2018. ORamaVR has attracted more than €1.3M in R&D grants and awards up to date. In 2020 ORamaVR concluded a €370K bridge round led by HTC Vive, a leader in enterprise virtual reality. | $4.5M | Seed | Jan 27, 2026 |  |
| Time-Travelling Milkman | Time-Travelling Milkman produce a plant-based cream from sunflower seeds, as an ingredient for dairy alternatives. | $2.4M | Seed | Sep 17, 2025 |  |
| Koios Care | Koios Care is a startup in the field of digital health. Their objective is to develop innovative and validated digital daily activity biomarkers in order to improve care while lowering costs. | $1.2M | Seed | Jun 16, 2025 |  |
| SolidWatts | SolidWatts enable the electrification of power-hungry industrial processes that require heat to fulfill a process. | $942.7K | Pre-Seed | Sep 06, 2024 |  |
| ORamaVR | ORamaVR (www.oramavr.com) is a deep technology, spatial computing startup, innovating the field of med-ed-tech Virtual Reality (VR) training simulation authoring platforms. Our technologies are based on state-of-the-art research by world-renowned scientists team members. This research is turned into a novel, symbiotic VR authoring and simulationplatform by our top engineers, medical professionals and business developers. ORamaVR was founded in 2016 and received initial €575K pre-seed financing from the VC PJ TECH CATALYST FUND in Greece. The company has moved its HQ to Geneva, Switzerland upon strategic partners' demand. ORamaVR is adopted by the USC Keck School of Medicine, Los Angeles, NYU Langone Medical centre in New York, the University of Geneva and the Inselspital Hospital system in Switzerland, FORTH and the University of Athens in Greece and recently Western Governors University, Fayetteville State University and the University of Michigan in USA. Medacta International, a leading Swiss medical implant manufacturer expressed high interest to collaborate intensively with ORamaVR. ORamaVR has been awarded in 2020 an Epic Games Mega-Grant, in 2019 the Augmented World Expo (AWE) Auggie award for "Best Societal Impact” and the prestigious FARE award, from the American Association of Hip and Knee Surgeons (AAHKS) in 2018. ORamaVR has attracted more than €1.3M in R&D grants and awards up to date. In 2020 ORamaVR concluded a €370K bridge round led by HTC Vive, a leader in enterprise virtual reality. |  | Seed |  |  |

8 of 8 investments shown.

## Co-investors
- [COREangels Climate](https://shizune.co/investors/profile/coreangels-climate) — VC Fund, 2 deals together
- [Kickfund](https://shizune.co/investors/profile/kickfund) — VC Fund, 2 deals together
- [AFI Ventures](https://shizune.co/investors/profile/afi-ventures) — VC Fund, 1 deal together
- [Almanac Ventures](https://shizune.co/investors/profile/almanac-ventures) — VC Fund, 1 deal together
- [Astylab Ventures](https://shizune.co/investors/profile/astylab-ventures) — VC Fund, 1 deal together
- [Big Pi Ventures](https://shizune.co/investors/profile/big-pi-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Reach Capital](https://shizune.co/investors/profile/reach-capital) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [GSV Ventures](https://shizune.co/investors/profile/gsv-acceleration) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund

## Featured in investor lists
- [Education Investors in Switzerland](https://shizune.co/investors/education-investors-switzerland)
- [Education VC Funds in Switzerland](https://shizune.co/investors/education-vc-funds-switzerland)
- [Medical Device Investors in Switzerland](https://shizune.co/investors/medical-device-investors-switzerland)
- [EdTech Investors in Switzerland](https://shizune.co/investors/edtech-investors-switzerland)
- [EdTech VC Funds in Switzerland](https://shizune.co/investors/edtech-vc-funds-switzerland)

## FAQ

### What does Evercurious VC invest in?

Evercurious VC invests primarily in Health Care, Medical and Chemical startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Evercurious VC's check size?

Evercurious VC typically joins rounds of $1.2M–$7.7M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Evercurious VC participates in.

### How do I contact Evercurious VC?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Evercurious VC?

The team at Evercurious VC includes Alex Vamvakas (Partner) and George Georgiadis (Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co